Moss, 5 May 2023

Holta Invest AS is in the process of simplifying its group structure whereby its
ownership in Gentian Diagnostics ASA, previously owned indirectly through Holta
Life Sciences AS (which is wholly owned by Holta Invest AS) and Holta Horisont
AS (which is 85% owned by Holta Invest AS) now are owned directly by Holta
Invest AS.

The above re-organization has been completed by each of Holta Horisont AS and
Holta Life Sciences AS on 5 May 2023 having sold all its 13,800 shares and
1,214,702 shares, respectively, in Gentian Diagnostics ASA to Holta Invest AS.
Following the transaction from Holta Horisont AS and Holta Life Sciences AS to
Holta Invest AS, Holta Invest AS holds 1,228,502 shares in Gentian,
corresponding to approximately 7.97 per cent of the total shares and votes
(based on 15,422,350 number of outstanding shares).

This disclosure is made pursuant to Section 4-2 of the Norwegian Securities
Trading Act.